We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients (PRD-MI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02128477
Recruitment Status : Completed
First Posted : May 1, 2014
Last Update Posted : January 25, 2017
Sponsor:
Information provided by (Responsible Party):
Thebiosignals.com

Brief Summary:
Increased periodic repolarization dynamics (PRD) indicate increased risk of death in cardiac patients. This study thoughts to prospectively validate the prognostic value of PRD in post-infarction patients.

Condition or disease
Myocardial Infarction

Detailed Description:

Periodic repolarization dynamics (PRD) reflect periodic changes of repolarization instability located in the low-frequency spectral range. Level of PRD can be assessed using a high resolution surface ECG recorded in the 12-leads of Frank leads configuration during resting conditions.

Increased levels of PRD have been associated with sympathetic overactivity and increased risk of mortality in survivors of acute myocardial infarction and patients undergoing a clinically indicated exercise test.


Study Type : Observational
Actual Enrollment : 754 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients: Validation Study
Actual Study Start Date : October 2010
Primary Completion Date : December 2016
Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack
U.S. FDA Resources




Primary Outcome Measures :
  1. Number of total deaths [ Time Frame: 24 months ]

Secondary Outcome Measures :
  1. Number of cardiovascular deaths [ Time Frame: 24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
myocardial infarction
Criteria

Inclusion Criteria:

  • previous myocardial infarction >4 weeks
  • age >18 years

Exclusion Criteria:

  • life expectancy < 1 year due to non-cardiac causes
  • unable to give informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02128477


Locations
Germany
Eberhard-Karls-University Tuebingen
Tuebingen, Baden-Württemberg, Germany, 72076
Sponsors and Collaborators
Thebiosignals.com

Responsible Party: Thebiosignals.com
ClinicalTrials.gov Identifier: NCT02128477     History of Changes
Other Study ID Numbers: BIO012014
First Posted: May 1, 2014    Key Record Dates
Last Update Posted: January 25, 2017
Last Verified: January 2017

Keywords provided by Thebiosignals.com:
Myocardial infarction
Repolarization instability
Ventricular fibrillation

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases